Pavel Raifeld, CFA, joined Innoviva as Chief Executive Officer in May 2020. Prior to that, Mr. Raifeld served on the investment team at Sarissa Capital Management LP, an investment management firm focused on improving strategies of companies to enhance shareholder value. Earlier, he was a senior member of the healthcare investment banking team at Credit Suisse. Previously, Mr. Raifeld worked as a consultant, primarily specializing in advising biopharmaceutical companies, at McKinsey & Company and The Boston Consulting Group. Mr. Raifeld earned an AB degree from Harvard University and an MBA degree from Columbia University.